|
Acumen Pharmaceuticals, Inc.
|
ABOS
|
██%
|
$170M
|
-1.9x
|
2.4x
|
|
Abpro Holdings, Inc.
|
ABP
|
██%
|
$310K
|
x
|
0.0x
|
|
Arcellx, Inc.
|
ACLX
|
██%
|
$6.65B
|
-74.1x
|
16.5x
|
|
Alpha Cognition Inc.
|
ACOG
|
██%
|
$116M
|
x
|
3.4x
|
|
Adaptimmune Therapeutics Plc
|
ADAP
|
██%
|
$77M
|
-13.2x
|
-11.8x
|
|
Adma Biologics, Inc.
|
ADMA
|
██%
|
$2.18B
|
14.8x
|
4.6x
|
|
Adaptive Biotechnologies Corp
|
ADPT
|
██%
|
$1.98B
|
-4.6x
|
9.0x
|
|
Adverum Biotechnologies, Inc.
|
ADVM
|
██%
|
$95M
|
-1.8x
|
2.2x
|
|
Agenus Inc
|
AGEN
|
██%
|
$114M
|
995.1x
|
33.5x
|
|
Agentix Corp.
|
AGTX
|
██%
|
$2M
|
x
|
249.3x
|
|
Aim Immunotech Inc.
|
AIM
|
██%
|
$2M
|
-0.5x
|
0.9x
|
|
Aim Immunotech Inc.
|
AIMI
|
██%
|
$1M
|
x
|
x
|
|
Alector, Inc.
|
ALEC
|
██%
|
$223M
|
-1.2x
|
7.3x
|
|
Aligos Therapeutics, Inc.
|
ALGS
|
██%
|
$41M
|
-19.2x
|
0.8x
|
|
Allogene Therapeutics, Inc.
|
ALLO
|
██%
|
$509M
|
-1.4x
|
1.7x
|
|
Alvotech
|
ALVO
|
██%
|
$1.07B
|
x
|
x
|
|
Amgen Inc
|
AMGN
|
██%
|
$189.58B
|
24.6x
|
21.9x
|
|
Apogee Therapeutics, Inc.
|
APGE
|
██%
|
$5.38B
|
-20.5x
|
4.3x
|
|
Aptose Biosciences Inc.
|
APTOF
|
██%
|
$4M
|
x
|
x
|
|
Argenx Se
|
ARGX
|
██%
|
$41.93B
|
x
|
x
|
|
Armata Pharmaceuticals, Inc.
|
ARMP
|
██%
|
$315M
|
-1.0x
|
16.4x
|
|
Artiva Biotherapeutics, Inc.
|
ARTV
|
██%
|
$133M
|
x
|
1.2x
|
|
Leonabio, Inc.
|
ATHA
|
██%
|
$23M
|
-0.2x
|
0.9x
|
|
Atara Biotherapeutics, Inc.
|
ATRA
|
██%
|
$35M
|
1.1x
|
4.7x
|
|
Atyr Pharma Inc
|
ATYR
|
██%
|
$76M
|
-3.6x
|
1.1x
|
|
Aura Biosciences, Inc.
|
AURA
|
██%
|
$425M
|
-4.9x
|
3.1x
|
|
Autolus Therapeutics Plc
|
AUTL
|
██%
|
$386M
|
x
|
1.5x
|
|
Anavex Life Sciences Corp.
|
AVXL
|
██%
|
$261M
|
-17.3x
|
2.1x
|
|
Bioatla, Inc.
|
BCAB
|
██%
|
$13M
|
-1.1x
|
23.3x
|
|
Biocardia, Inc.
|
BCDA
|
██%
|
$12M
|
-0.6x
|
13.9x
|
|
Brainstorm Cell Therapeutics Inc.
|
BCLI
|
██%
|
$8M
|
-4.9x
|
6.0x
|
|
Biocryst Pharmaceuticals Inc
|
BCRX
|
██%
|
$2.37B
|
9.0x
|
70.5x
|
|
Black Diamond Therapeutics, Inc.
|
BDTX
|
██%
|
$116M
|
5.2x
|
1.0x
|
|
Beam Therapeutics Inc.
|
BEAM
|
██%
|
$2.23B
|
-12.6x
|
1.8x
|
|
Biogen Inc.
|
BIIB
|
██%
|
$27.54B
|
21.3x
|
1.9x
|
|
Biontech Se
|
BNTX
|
██%
|
$21.43B
|
x
|
x
|
|
Cabaletta Bio, Inc.
|
CABA
|
██%
|
$286M
|
-1.6x
|
2.1x
|
|
Candel Therapeutics, Inc.
|
CADL
|
██%
|
$328M
|
-4.6x
|
6.3x
|
|
C4 Therapeutics, Inc.
|
CCCC
|
██%
|
$228M
|
-2.6x
|
0.9x
|
|
Cidara Therapeutics, Inc.
|
CDTX
|
██%
|
$6.49B
|
-1.0x
|
15.4x
|
|
Creative Medical Technology Holdings, Inc.
|
CELZ
|
██%
|
$7M
|
-3.4x
|
1.0x
|
|
Cero Therapeutics Holdings, Inc.
|
CERO
|
██%
|
$720K
|
x
|
-196.2x
|
|
Cullinan Therapeutics, Inc.
|
CGEM
|
██%
|
$847M
|
-4.1x
|
2.1x
|
|
Compugen Ltd
|
CGEN
|
██%
|
$188M
|
x
|
1.8x
|
|
Cg Oncology, Inc.
|
CGON
|
██%
|
$5.16B
|
x
|
6.9x
|
|
Cognition Therapeutics Inc
|
CGTX
|
██%
|
$68M
|
-0.5x
|
2.0x
|
|
Coherus Oncology, Inc.
|
CHRS
|
██%
|
$265M
|
1.6x
|
4.4x
|
|
Calidi Biotherapeutics, Inc.
|
CLDI
|
██%
|
$2M
|
-0.9x
|
0.6x
|
|
Cellectis S.A.
|
CLLS
|
██%
|
$319M
|
x
|
x
|
|
Compass Therapeutics, Inc.
|
CMPX
|
██%
|
$909M
|
-4.8x
|
4.6x
|
|
Mosaic Immunoengineering Inc.
|
CPMV
|
██%
|
$5M
|
x
|
20.9x
|
|
Caribou Biosciences, Inc.
|
CRBU
|
██%
|
$142M
|
-1.5x
|
1.0x
|
|
Cardiff Oncology, Inc.
|
CRDF
|
██%
|
$106M
|
-4.0x
|
2.3x
|
|
Cardiol Therapeutics Inc.
|
CRDL
|
██%
|
$136M
|
x
|
x
|
|
Curis Inc
|
CRIS
|
██%
|
$20M
|
-0.3x
|
3.8x
|
|
Crispr Therapeutics Ag
|
CRSP
|
██%
|
$4.25B
|
-12.1x
|
2.2x
|
|
Champions Oncology, Inc.
|
CSBR
|
██%
|
$80M
|
32.9x
|
18.6x
|
|
Cel Sci Corp
|
CVM
|
██%
|
$26M
|
-0.9x
|
2.3x
|
|
Dbv Technologies S.A.
|
DBVT
|
██%
|
$1.13B
|
-3.3x
|
21.3x
|
|
Dbv Technologies S.A.
|
DBVTF
|
██%
|
$10K
|
x
|
0.0x
|
|
Ginkgo Bioworks Holdings, Inc.
|
DNA
|
██%
|
$319M
|
-13.9x
|
0.6x
|
|
Denali Therapeutics Inc.
|
DNLI
|
██%
|
$2.82B
|
-8.7x
|
2.8x
|
|
Precision Biosciences Inc
|
DTIL
|
██%
|
$131M
|
-2.2x
|
1.4x
|
|
Dyadic International Inc
|
DYAI
|
██%
|
$31M
|
-7.3x
|
11.7x
|
|
Editas Medicine, Inc.
|
EDIT
|
██%
|
$218M
|
-0.8x
|
8.0x
|
|
Elutia Inc.
|
ELUT
|
██%
|
$44M
|
0.8x
|
1.6x
|
|
Engene Holdings Inc.
|
ENGN
|
██%
|
$414M
|
3.7x
|
1.5x
|
|
Entera Bio Ltd.
|
ENTX
|
██%
|
$51M
|
8.5x
|
3.9x
|
|
Viskase Holdings, Inc.
|
ENZN
|
██%
|
$4M
|
x
|
10.3x
|
|
Estrella Immunopharma, Inc.
|
ESLA
|
██%
|
$42M
|
-3.1x
|
289.4x
|
|
Evaxion A/S
|
EVAX
|
██%
|
$31M
|
x
|
x
|
|
Exelixis, Inc.
|
EXEL
|
██%
|
$11.01B
|
14.1x
|
5.1x
|
|
Exozymes Inc.
|
EXOZ
|
██%
|
$61M
|
x
|
18.1x
|
|
Fate Therapeutics Inc
|
FATE
|
██%
|
$122M
|
-1.3x
|
0.6x
|
|
4d Molecular Therapeutics, Inc.
|
FDMT
|
██%
|
$438M
|
-3.0x
|
0.9x
|
|
Fennec Pharmaceuticals Inc.
|
FENC
|
██%
|
$210M
|
1758.3x
|
5.9x
|
|
Finch Therapeutics Group, Inc.
|
FNCH
|
██%
|
$15M
|
-0.1x
|
1.1x
|
|
Futuretech Ii Acquisition Corp.
|
FTII
|
██%
|
$52M
|
x
|
-0.7x
|
|
Futuretech Ii Acquisition Corp.
|
FTIIU
|
██%
|
$14M
|
x
|
-0.8x
|
|
Gilead Sciences, Inc.
|
GILD
|
██%
|
$169.20B
|
19.9x
|
7.5x
|
|
Monte Rosa Therapeutics, Inc.
|
GLUE
|
██%
|
$1.32B
|
59.5x
|
5.7x
|
|
Genenta Science S.P.A.
|
GNTA
|
██%
|
$16M
|
x
|
1.3x
|
|
Green Planet Bio Engineering Co. Ltd.
|
GPLB
|
██%
|
$340K
|
x
|
x
|
|
Halozyme Therapeutics, Inc.
|
HALO
|
██%
|
$7.32B
|
23.1x
|
149.9x
|
|
Humacyte, Inc.
|
HUMA
|
██%
|
$128M
|
-3.3x
|
41.1x
|
|
Immunitybio, Inc.
|
IBRX
|
██%
|
$6.74B
|
-3.6x
|
57.4x
|
|
Inhibikase Therapeutics, Inc.
|
IKT
|
██%
|
$194M
|
-1.0x
|
2.7x
|
|
Immunocore Holdings Plc
|
IMCR
|
██%
|
$1.48B
|
x
|
3.9x
|
|
Immatics N.V.
|
IMTX
|
██%
|
$1.25B
|
x
|
x
|
|
Immunovant, Inc.
|
IMVT
|
██%
|
$4.85B
|
-14.5x
|
4.9x
|
|
In8bio, Inc.
|
INAB
|
██%
|
$13M
|
x
|
0.5x
|
|
Inhibrx Biosciences, Inc.
|
INBX
|
██%
|
$873M
|
-6.8x
|
109.2x
|
|
Mink Therapeutics, Inc.
|
INKT
|
██%
|
$45M
|
-1.5x
|
6.7x
|
|
Inmune Bio, Inc.
|
INMB
|
██%
|
$30M
|
-2.5x
|
1.3x
|
|
Intensity Therapeutics, Inc.
|
INTS
|
██%
|
$14M
|
-2.2x
|
1.2x
|
|
Iovance Biotherapeutics, Inc.
|
IOVA
|
██%
|
$1.45B
|
-4.5x
|
2.1x
|
|
Century Therapeutics, Inc.
|
IPSC
|
██%
|
$365M
|
-0.7x
|
2.3x
|
|
Invivyd, Inc.
|
IVVD
|
██%
|
$367M
|
-0.4x
|
1.5x
|
|
Jasper Therapeutics, Inc.
|
JSPR
|
██%
|
$25M
|
-3.2x
|
6.1x
|
|
Kalaris Therapeutics, Inc.
|
KLRS
|
██%
|
$121M
|
x
|
1.5x
|
|
Klotho Neurosciences, Inc.
|
KLTO
|
██%
|
$56M
|
x
|
5.7x
|
|
Kodiak Sciences Inc.
|
KOD
|
██%
|
$2.35B
|
-2.5x
|
15.0x
|
|
Krystal Biotech, Inc.
|
KRYS
|
██%
|
$7.21B
|
35.2x
|
5.9x
|
|
Kymera Therapeutics, Inc.
|
KYMR
|
██%
|
$6.46B
|
-17.8x
|
4.1x
|
|
Kyverna Therapeutics, Inc.
|
KYTX
|
██%
|
$458M
|
x
|
2.0x
|
|
Ladrx Corp
|
LADX
|
██%
|
$20K
|
x
|
0.1x
|
|
Lineage Cell Therapeutics, Inc.
|
LCTX
|
██%
|
$360M
|
-4.7x
|
8.1x
|
|
Lenz Therapeutics, Inc.
|
LENZ
|
██%
|
$357M
|
-6.7x
|
1.8x
|
|
Liminatus Pharma, Inc.
|
LIMN
|
██%
|
$10M
|
x
|
x
|
|
Lexeo Therapeutics, Inc.
|
LXEO
|
██%
|
$385M
|
-0.4x
|
1.6x
|
|
Maze Therapeutics, Inc.
|
MAZE
|
██%
|
$1.43B
|
x
|
4.0x
|
|
Mesoblast Ltd
|
MESO
|
██%
|
$1.90B
|
x
|
x
|
|
Meiragtx Holdings Plc
|
MGTX
|
██%
|
$596M
|
-3.4x
|
201.5x
|
|
Metagenomi Therapeutics, Inc.
|
MGX
|
██%
|
$50M
|
x
|
0.3x
|
|
Molecular Partners Ag
|
MOLN
|
██%
|
$160M
|
x
|
x
|
|
Moderna, Inc.
|
MRNA
|
██%
|
$20.02B
|
-3.2x
|
2.3x
|
|
Neurocrine Biosciences Inc
|
NBIX
|
██%
|
$12.80B
|
26.7x
|
3.9x
|
|
Nkgen Biotech, Inc.
|
NKGN
|
██%
|
$2M
|
-0.1x
|
-0.2x
|
|
Neumora Therapeutics, Inc.
|
NMRA
|
██%
|
$399M
|
-3.9x
|
3.0x
|
|
Novavax Inc
|
NVAX
|
██%
|
$1.51B
|
3.4x
|
40.0x
|
|
Ocugen, Inc.
|
OCGN
|
██%
|
$547M
|
-4.3x
|
154.7x
|
|
Outlook Therapeutics, Inc.
|
OTLK
|
██%
|
$22M
|
-0.2x
|
2.1x
|
|
Palisade Bio, Inc.
|
PALI
|
██%
|
$291M
|
-0.2x
|
2.3x
|
|
Passage Bio, Inc.
|
PASG
|
██%
|
$22M
|
-0.6x
|
1.2x
|
|
Vaxcyte, Inc.
|
PCVX
|
██%
|
$7.62B
|
-20.4x
|
2.8x
|
|
Biomx Inc.
|
PHGE
|
██%
|
$8M
|
1.5x
|
0.8x
|
|
Pluri Inc.
|
PLUR
|
██%
|
$34M
|
-1.4x
|
352.9x
|
|
Protalix Biotherapeutics, Inc.
|
PLX
|
██%
|
$173M
|
41.2x
|
3.6x
|
|
Pharmacyte Biotech, Inc.
|
PMCB
|
██%
|
$8M
|
0.3x
|
0.2x
|
|
Prime Medicine, Inc.
|
PRME
|
██%
|
$617M
|
-1.5x
|
5.1x
|
|
Prokidney Corp.
|
PROK
|
██%
|
$526M
|
x
|
0.0x
|
|
Qiagen N.V.
|
QGEN
|
██%
|
$9.11B
|
x
|
2.6x
|
|
Quince Therapeutics, Inc.
|
QNCX
|
██%
|
$5M
|
-1.7x
|
5.1x
|
|
Qrons Inc.
|
QRON
|
██%
|
$150K
|
x
|
x
|
|
Replimune Group, Inc.
|
REPL
|
██%
|
$602M
|
-3.8x
|
2.9x
|
|
Repligen Corp
|
RGEN
|
██%
|
$6.61B
|
135.2x
|
3.1x
|
|
Regenxbio Inc.
|
RGNX
|
██%
|
$418M
|
-1.8x
|
4.1x
|
|
Relay Therapeutics, Inc.
|
RLAY
|
██%
|
$1.84B
|
-2.0x
|
3.2x
|
|
Revolution Medicines, Inc.
|
RVMD
|
██%
|
$19.08B
|
-11.1x
|
11.7x
|
|
Recursion Pharmaceuticals, Inc.
|
RXRX
|
██%
|
$1.58B
|
-4.7x
|
1.4x
|
|
Sab Biotherapeutics, Inc.
|
SABS
|
██%
|
$273M
|
20.6x
|
1.8x
|
|
Sana Biotechnology, Inc.
|
SANA
|
██%
|
$740M
|
-2.1x
|
4.6x
|
|
Scilex Holding Co
|
SCLX
|
██%
|
$47M
|
-0.4x
|
4.5x
|
|
Scinai Immunotherapeutics Ltd.
|
SCNI
|
██%
|
$2M
|
-287.8x
|
0.3x
|
|
Sangamo Therapeutics, Inc
|
SGMO
|
██%
|
$82M
|
-1.6x
|
13.1x
|
|
Solid Biosciences Inc.
|
SLDB
|
██%
|
$715M
|
-0.9x
|
4.0x
|
|
Silexion Therapeutics Corp
|
SLXN
|
██%
|
$4M
|
x
|
1.5x
|
|
Senti Biosciences, Inc.
|
SNTI
|
██%
|
$24M
|
-1.1x
|
4.3x
|
|
Scholar Rock Holding Corp
|
SRRK
|
██%
|
$5.22B
|
-18.5x
|
21.3x
|
|
Surrozen, Inc./De
|
SRZN
|
██%
|
$343M
|
-0.5x
|
7.3x
|
|
Sutro Biopharma, Inc.
|
STRO
|
██%
|
$356M
|
-1.0x
|
8.0x
|
|
Protara Therapeutics, Inc.
|
TARA
|
██%
|
$278M
|
-2.1x
|
1.4x
|
|
Tarsus Pharmaceuticals, Inc.
|
TARS
|
██%
|
$2.87B
|
-12.4x
|
8.4x
|
|
Tc Biopharm (Holdings) Plc
|
TCBPY
|
██%
|
$10K
|
x
|
0.0x
|
|
Tscan Therapeutics, Inc.
|
TCRX
|
██%
|
$57M
|
-4.6x
|
0.5x
|
|
Bio-Techne Corp
|
TECH
|
██%
|
$8.20B
|
101.1x
|
4.1x
|
|
Tectonic Therapeutic, Inc.
|
TECX
|
██%
|
$587M
|
-8.9x
|
2.3x
|
|
Instil Bio, Inc.
|
TIL
|
██%
|
$56M
|
-1.1x
|
0.5x
|
|
Tenaya Therapeutics, Inc.
|
TNYA
|
██%
|
$159M
|
-2.5x
|
1.3x
|
|
Tourmaline Bio, Inc.
|
TRML
|
██%
|
$1.23B
|
-3.5x
|
4.8x
|
|
Taysha Gene Therapies, Inc.
|
TSHA
|
██%
|
$1.26B
|
-3.0x
|
5.1x
|
|
Titan Pharmaceuticals Inc
|
TTNP
|
██%
|
$6M
|
-0.5x
|
2.2x
|
|
Tevogen Bio Holdings Inc.
|
TVGN
|
██%
|
$17M
|
x
|
1274.2x
|
|
Twist Bioscience Corp
|
TWST
|
██%
|
$2.85B
|
-12.6x
|
6.3x
|
|
Voyager Acquisition Corp./Cayman Islands
|
VACH
|
██%
|
$372M
|
41.3x
|
0.0x
|
|
Voyager Acquisition Corp./Cayman Islands
|
VACHU
|
██%
|
$68M
|
6.7x
|
0.0x
|
|
Valneva Se
|
VALN
|
██%
|
$548M
|
x
|
x
|
|
Vericel Corp
|
VCEL
|
██%
|
$1.61B
|
97.7x
|
4.6x
|
|
Vir Biotechnology, Inc.
|
VIR
|
██%
|
$1.47B
|
-2.0x
|
1.8x
|
|
Vivosim Labs, Inc.
|
VIVS
|
██%
|
$4M
|
x
|
1.0x
|
|
Vor Biopharma Inc.
|
VOR
|
██%
|
$738M
|
-0.6x
|
11.2x
|
|
Vaxart, Inc.
|
VXRT
|
██%
|
$146M
|
8.9x
|
1.7x
|
|
Voyager Therapeutics, Inc.
|
VYGR
|
██%
|
$238M
|
570.6x
|
1.2x
|
|
Windtree Therapeutics Inc /De/
|
WINT
|
██%
|
$320K
|
-0.4x
|
0.1x
|
|
X4 Pharmaceuticals, Inc
|
XFOR
|
██%
|
$375M
|
6.4x
|
2.0x
|
|
Zeo Scientifix, Inc.
|
ZEOX
|
██%
|
$17M
|
x
|
25.0x
|
|
Zivo Bioscience, Inc.
|
ZIVO
|
██%
|
$26M
|
-31.3x
|
17.0x
|
|
Zura Bio Ltd
|
ZURA
|
██%
|
$565M
|
x
|
5.6x
|
